Docket Room.
HB 4196·WV·house

To offer long-acting reversible contraception to patients receiving methadone and suboxone at the treatment facility for the methadone and suboxone

Signed into LawFiled Jan 14, 2026
Sponsor: Sarah Drennan (R)
Latest Action

H Chapter 181, Acts, Regular Session, 2026

Jun 29, 2026

Summary

The enacted amendment to the Medication‑Assisted Treatment Program Licensing Act adds a duty for methadone and buprenorphine clinics to provide non‑coercive contraceptive counseling and make long‑acting reversible contraception (LARC) available to patients. If a clinic does not have a qualified provider or equipment, it must refer patients to a licensed provider. The rule applies to all licensed MAT facilities and becomes effective 90 days after the governor’s signature (May 21 2026).

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get an email when HB 4196 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HB 4196 free

Or ask your AI assistant about HB 4196 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice